The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition
Author:
Affiliation:
1. Division of Hematology & Medical Oncology,
2. Knight Cancer Institute,
3. Howard Hughes Medical Institute, and
4. Department of Cell & Developmental Biology, Oregon Health & Science University, Portland, OR
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/122/22/3628/1372032/3628.pdf
Reference13 articles.
1. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.;Maxson;N Engl J Med,2013
2. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.;Pardanani;Leukemia,2013
3. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.;Beekman;Blood,2012
4. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.;Dong;N Engl J Med,1995
5. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia.;Ward;Blood,1999
Cited by 93 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hereditary chronic neutrophilic leukemia in a four‐generation family without transformation to acute leukemia;American Journal of Hematology;2024-06-27
2. Enhanced MAPK signaling induced by CSF3R mutants confers dependence to DUSP1 for leukemic transformation;Blood Advances;2024-05-31
3. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management;American Journal of Hematology;2024-04-21
4. Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine;Frontiers in Oncology;2024-02-07
5. Research progress of additional pathogenic mutations in chronic neutrophilic leukemia;Annals of Hematology;2023-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3